About eMAX Health
Connecting strategy, evidence, patient services,
& pharmacy infrastructure for modern access
Bringing a therapy to market requires more than isolated expertise.
​
Manufacturers need insight into how products will be evaluated, evidence that supports access decisions, programs that help patients start and stay on therapy, and infrastructure that can support complex dispensing models.
​
eMAX Health helps align these moving parts so access strategy, program design, and execution work together from planning through launch and beyond.
Our Leadership
Our leadership team brings decades of experience across market access, real-world evidence, HEOR, patient services, pharmacy, healthcare technology, and life sciences commercialization, helping shape the strategic direction and operational depth behind eMAX Health.
Julian Casciano | Chairman & CEO
Market access strategy • Pharmaceutical commercialization • Payer strategy • Real-world evidence • AI-enabled access technology
Julian leads eMAX Health’s mission to modernize market access and patient access strategy for pharmaceutical and biotech innovators. He brings more than 30 years of experience across healthcare consulting, commercialization, payer strategy, outcomes research, and entrepreneurship, with prior leadership roles at Biovest International, Analytica International, KPMG Peat Marwick, and Physicians World. His work includes advancing proprietary platforms such as MAVA® and HealthPACER®, helping manufacturers navigate pricing, reimbursement, stakeholder engagement, and access strategy with greater speed and insight.
Eric Bishea | President, eMAX Health Systems
Market access insights • Commercialization strategy • Managed markets • Stakeholder engagement • MAVA® strategy
Eric leads eMAX Health Systems, including the strategic direction and operational execution of MAVA®. He brings more than three decades of experience across sales, managed markets, commercialization, healthcare data, and market access strategy, with prior leadership roles at GlobalData, EVERSANA, The Access Group, Catalyst Medical Communications, Fusion Medical Communications, Searle, Pharmacia, and Allergan. His background includes building and leading global consulting and commercialization teams that support pharmaceutical and biotech brands with competitive intelligence, market assessment, stakeholder engagement, and brand growth strategy.
Mary Lynn Kelley | President, eMAX Health Patient Services
Patient services strategy • Hub operations • Reimbursement
Program design • Manufacturer partnerships
Mary Lynn leads eMAX’s full suite of patient support solutions, with accountability for program strategy, operational execution, and manufacturer client partnerships across oncology, rare disease, immunology, neurology, and other complex therapy areas. Her prior leadership roles at TGaS Advisors/Trinity, PharmaCord, and RxCrossroads/McKesson included oversight of 65+ access programs and partnerships with 30+ pharmaceutical manufacturers.
Kori Lambert | Chief Financial Officer
Financial operations • Corporate FP&A • M&A integration • Systems implementation • Operational efficiency
Kori leads financial operations for eMAX Health, supporting the financial discipline, reporting infrastructure, and operational scalability behind the company’s growth. She brings experience across M&A integration, corporate FP&A, forecasting, systems implementation, cost controls, and KPI-driven performance management, with prior leadership roles at Strategen, Certara’s Regulatory & Access division, and the University of Pennsylvania.
Why We're Different
eMAX Health was designed to reduce fragmentation across access strategy, evidence generation, patient services execution, technology, and non-commercial pharmacy infrastructure, capabilities that are often managed across separate partners.
Built Across the Access Lifecycle
eMAX Health brings together market access strategy, real-world evidence, patient services, and pharmacy infrastructure within one coordinated organization.
Led by Access, Evidence, Patient Services, and Pharmacy Operators
Our leadership brings experience across commercialization strategy, HEOR/RWE, hub operations, healthcare technology, and pharmacy execution.
Designed to Reduce Handoffs Between Strategy and Execution
By aligning insight, planning, patient support, and pharmacy infrastructure, eMAX Health helps organizations move from access strategy to real-world program execution with greater continuity.
The eMAX Health Ecosystem
Each organization has a distinct role, but the model is designed to support continuity across market access strategy, patient services execution, and pharmacy infrastructure.
